Share this post on:

Product Name :
Flavoxate Hydrochloride

Search keywords :
Flavoxate

drugId :
null

Target Vo:
Calcium release-activated calcium channel protein 1

Target Vo Short Name :
CRACM1

Moa_Name:
Calcium release-activated calcium channel protein 1 blockers

First Approval Country :
United States

First Approval Date Filter:
1970

Origin Company_Name :
Johnson & Johnson

Active Company_Name :
Nippon Shinyaku Co Ltd

Active Indication_Name:
Urinary Bladder, Overactive

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-HSF1 (Ser326) Antibody(YA894) web
Phospho-BTK(Y223) Rabbit mAb Description
SOX1 Antibody: SOX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SOX1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related